Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) General Information
Description
The gastrointestinal drugs commercialization rights.
Contact Information
Website
www.rebyota.comCorporate Office
- Switzerland
Corporate Office
- Switzerland
Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) FAQs
-
Where is Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) headquartered?
Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) is headquartered in Switzerland.
-
What industry is Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) in?
Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)’s primary industry is Buildings and Property.
-
Is Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) a private or public company?
Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) is a Private company.
-
What is the current valuation of Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)?
The current valuation of Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) is .
-
What is Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)’s current revenue?
The current revenue for Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) is .
-
Who are Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)’s investors?
Ferring has invested in Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights).
-
When was Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) acquired?
Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) was acquired on 01-Sep-2026.
-
Who acquired Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights)?
Ferring Pharmaceuticals (Rebyota and Clenpiq Commercialization Rights) was acquired by RedHill Biopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process